Global Fund Lp Lind II Sells 381,676 Shares of ReWalk Robotics Ltd. (NASDAQ:LFWD) Stock

ReWalk Robotics Ltd. (NASDAQ:LFWD) major shareholder Global Fund Lp Lind II sold 381,676 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $3.36, for a total transaction of $1,282,431.36. Following the sale, the insider now directly owns 1,049,430 shares of the company’s stock, valued at approximately $3,526,084.80. This represents a 26.67 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

ReWalk Robotics Stock Down 4.3 %

Shares of LFWD opened at $1.90 on Friday. ReWalk Robotics Ltd. has a 52 week low of $1.41 and a 52 week high of $7.92. The stock has a market cap of $16.69 million, a price-to-earnings ratio of -0.76 and a beta of 2.08. The business has a 50-day simple moving average of $1.94 and a two-hundred day simple moving average of $2.88.

ReWalk Robotics (NASDAQ:LFWD) last released its earnings results on Tuesday, November 12th. The company reported ($0.35) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.08). ReWalk Robotics had a negative return on equity of 43.02% and a negative net margin of 77.21%. The firm had revenue of $6.13 million for the quarter, compared to the consensus estimate of $8.38 million. During the same quarter in the previous year, the business posted ($0.56) EPS. On average, equities analysts anticipate that ReWalk Robotics Ltd. will post -1.78 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in ReWalk Robotics stock. Dimensional Fund Advisors LP purchased a new stake in shares of ReWalk Robotics Ltd. (NASDAQ:LFWD) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned 0.16% of ReWalk Robotics as of its most recent SEC filing. 26.76% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and set a $13.00 price objective on shares of ReWalk Robotics in a research report on Wednesday, November 13th.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.